Michelle Porritt

6PUBLICATIONS

31CO-AUTHORS

Molecular targetsGene and molecular therapyPowder and particle technologyReaction engineering (excl. nuclear reactions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Aug 26, 2026

Single-cell and in vivo profiling reveal heterogeneous and organ-specific CRISPR-Cas9 off-target and translocation outcomes.

|Nov 07, 2024

Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles.

Dmitrii Degtev, Jack Bravo, Aikaterini Emmanouilidi

|Jan 22, 2021

Universal toxin-based selection for precise genome engineering in human cells.

Songyuan Li, Nina Akrap, Silvia Cerboni

|Sep 30, 2020

Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery.

Anders Lundin, Michelle J Porritt, Himjyot Jaiswal

|Apr 20, 2019

Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq.

Beeke Wienert, Stacia K Wyman, Christopher D Richardson

Pageof 1

Frequent Collaborators

Marcello Maresca

Grzegorz Sienski

Anders Lundin

Benjamin J M Taylor

Niklas Selfjord

Suman Mitra

Pinar Akcakaya

Matthew A Coelho

Songyuan Li

Mark Behlke

Frequent Collaborators

Marcello Maresca

Grzegorz Sienski

Anders Lundin

Benjamin J M Taylor